← Open Payments lookup

JENNY FARRIS: Open Payments

NPI 1417662925 · TISHOMINGO, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$657 in 46 payments from 10 companies in 2025. Trend: 2023 $28 · 2024 $198 · 2025 $657

Food & beverage: $657
CompanyPaymentsAmount
ABBVIE INC.30$282
Phathom Pharmaceuticals, Inc.1$105
Novo Nordisk Inc3$49
Amgen Inc.3$48
IBSA Pharma Inc.2$42
AstraZeneca Pharmaceuticals LP2$38
Esperion Therapeutics, Inc.2$33
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$25
Boehringer Ingelheim Pharmaceuticals, Inc.1$18
Lilly USA, LLC1$18

Products named: VRAYLAR, VOQUEZNA, UBRELVY, QULIPTA, Wegovy, OTEZLA, Tirosint, FARXIGA.

Industry payments across MS — which companies pay providers there.